Targeting cardiac fibrosis with engineered T cells
2019 · Nature · 762 citations
https://doi.org/10.1038/s41586-019-1546-z
H
Haig Aghajanian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
3.2K
Citations
22
h-index
25
i10-index
Haig Aghajanian is an academic researcher from Therapeutics Clinical Research. The author has contributed to research in topics: CAR-T cell therapy research & Congenital heart defects research & Axon Guidance and Neuronal Signaling. The author has an h-index of 22, co-authored 39 publications.
ORCID: 0000-0002-8317-0157Papers by this author
worksIn vivo CAR T cell generation to treat cancer and autoimmune disease
2025 · Science · 155 citations
https://doi.org/10.1126/science.ads8473
Semaphorin 3d and Semaphorin 3e Direct Endothelial Motility through Distinct Molecular Signaling Pathways
2014 · Journal of Biological Chemistry · 69 citations
https://doi.org/10.1074/jbc.m113.544833
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
2024 · Proceedings of the National Academy of Sciences · 41 citations
https://doi.org/10.1073/pnas.2319856121
Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor
2016 · Nature Communications · 40 citations
https://doi.org/10.1038/ncomms12038
Pax3 and Hippo Signaling Coordinate Melanocyte Gene Expression in Neural Crest
2015 · Cell Reports · 6 citations
https://doi.org/10.1016/j.celrep.2015.01.041
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat